Try our beta test site
1 study found for:    NCT00805129
Show Display Options
Rank Status Study
1 Active, not recruiting Everolimus (RAD001) in Metastatic Transitional Cell Carcinoma of the Urothelium
Conditions: Bladder Cancer;   Metastatic Transitional Cell Carcinoma
Intervention: Drug: Everolimus

Study has passed its completion date and status has not been verified in more than two years.